Commensal bacteria mediated defenses against pathogens

Current Opinion in Immunology

Volumn 29, Issue 1, 2014, Pages 16-22

  Abt, Michael C ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; COMMENSAL; DEFENSE MECHANISM; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INTESTINE; NONHUMAN; NUTRIENT; NUTRIENT SUPPLY; ORGANISMAL INTERACTION; PATHOGEN CLEARANCE; PATHOGENICITY; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; BACTERIA; IMMUNOLOGY; INFECTION; INFECTION CONTROL; MICROBIOLOGY;

ANIMALS; BACTERIA; HUMANS; INFECTION; INFECTION CONTROL; INFLAMMATION; INTESTINES;

EID: 84897939843     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.03.003     Document Type: Review

References (75)

1. Whitman W.B., Coleman D.C., Wiebe W.J. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 1998, 95:6578-6583.
2. Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-gut microbiota metabolic interactions. Science 2012, 336:1262-1267.
3. McLoughlin R.M., Mills K.H. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol 2011, 127:1097-1107. quiz 1108-099.
4. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
5. Kamada N., Seo S.U., Chen G.Y., Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013, 13:321-335.
6. Barthel M., Hapfelmeier S., Quintanilla-Martinez L., Kremer M., Rohde M., Hogardt M., Pfeffer K., Russmann H., Hardt W.D. Pretreatment of mice with streptomycin provides a salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 2003, 71:2839-2858.
7. Buffie C.G., Jarchum I., Equinda M., Lipuma L., Gobourne A., Viale A., Ubeda C., Xavier J., Pamer E.G. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 2012, 80:62-73.
8. Sekirov I., Tam N.M., Jogova M., Robertson M.L., Li Y., Lupp C., Finlay B.B. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008, 76:4726-4736.
9. Donskey C.J., Chowdhry T.K., Hecker M.T., Hoyen C.K., Hanrahan J.A., Hujer A.M., Hutton-Thomas R.A., Whalen C.C., Bonomo R.A., Rice L.B. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000, 343:1925-1932.
10. Donskey C.J. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis 2006, 43(Suppl 2):S62-S69.
11. Owens R.C., Donskey C.J., Gaynes R.P., Loo V.G., Muto C.A. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S19-S31.
12. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., Speelman P., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
13. Song Y., Garg S., Girotra M., Maddox C., von Rosenvinge E.C., Dutta A., Dutta S., Fricke W.F. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS ONE 2013, 8:e81330.
14. Lawley T.D., Clare S., Walker A.W., Stares M.D., Connor T.R., Raisen C., Goulding D., Rad R., Schreiber F., Brandt C., Deakin L.J., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012, 8:e1002995.
15. Ubeda C., Bucci V., Caballero S., Djukovic A., Toussaint N.C., Equinda M., Lipuma L., Ling L., Gobourne A., No D., Taur Y., et al. Intestinal microbiota containing barnesiella species cures vancomycin-resistant enterococcus faecium colonization. Infect Immun 2013, 81:965-973.
16. Endt K., Stecher B., Chaffron S., Slack E., Tchitchek N., Benecke A., Van Maele L., Sirard J.C., Mueller A.J., Heikenwalder M., Macpherson A.J., et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal salmonella diarrhea. PLoS Pathog 2010, 6:e1001097.
17. Reeves A.E., Koenigsknecht M.J., Bergin I.L., Young V.B. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family lachnospiraceae. Infect Immun 2012, 80:3786-3794.
18. Willing B.P., Vacharaksa A., Croxen M., Thanachayanont T., Finlay B.B. Altering host resistance to infections through microbial transplantation. PLoS ONE 2011, 6:e26988.
19. Lee S.M., Donaldson G.P., Mikulski Z., Boyajian S., Ley K., Mazmanian S.K. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013, 501:426-429.
20. Degnan P.H., Barry N.A., Mok K.C., Taga M.E., Goodman A.L. Human gut microbes use multiple transporters to distinguish vitamin b12 analogs and compete in the gut. Cell Host Microbe 2014, 15:47-57.
21. Collins F.M., Carter P.B. Growth of salmonellae in orally infected germfree mice. Infect Immun 1978, 21:41-47.
22. Butterton J.R., Ryan E.T., Shahin R.A., Calderwood S.B. Development of a germfree mouse model of vibrio cholerae infection. Infect Immun 1996, 64:4373-4377.
23. Kamada N., Kim Y.G., Sham H.P., Vallance B.A., Puente J.L., Martens E.C., Nunez G. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012, 336:1325-1329.
24. Ng K.M., Ferreyra J.A., Higginbottom S.K., Lynch J.B., Kashyap P.C., Gopinath S., Naidu N., Choudhury B., Weimer B.C., Monack D.M., Sonnenburg J.L. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
25. Hammami R., Fernandez B., Lacroix C., Fliss I. Anti-infective properties of bacteriocins: an update. Cell Mol Life Sci 2013, 70:2947-2967.
26. Rea M.C., Sit C.S., Clayton E., O'Connor P.M., Whittal R.M., Zheng J., Vederas J.C., Ross R.P., Hill C. Thuricin cd, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A 2010, 107:9352-9357.
27. Rea M.C., Alemayehu D., Casey P.G., O'Connor P.M., Lawlor P.G., Walsh M., Shanahan F., Kiely B., Ross R.P., Hill C. Bioavailability of the anti-clostridial bacteriocin thuricin cd in gastrointestinal tract. Microbiology 2014, 160(Pt 2):439-445.
28. Gantois I., Ducatelle R., Pasmans F., Haesebrouck F., Hautefort I., Thompson A., Hinton J.C., Van Immerseel F. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 2006, 72:946-949.
29. Fanning S., Hall L.J., Cronin M., Zomer A., MacSharry J., Goulding D., Motherway M.O., Shanahan F., Nally K., Dougan G., van Sinderen D. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 2012, 109:2108-2113.
30. Yoshimura K., Matsui T., Itoh K. Prevention of escherichia coli o157:H7 infection in gnotobiotic mice associated with bifidobacterium strains. Antonie van Leeuwenhoek 2010, 97:107-117.
31. Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., Tobe T., Clarke J.M., Topping D.L., Suzuki T., Taylor T.D., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
32. Minot S., Sinha R., Chen J., Li H., Keilbaugh S.A., Wu G.D., Lewis J.D., Bushman F.D. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 2011, 21:1616-1625.
33. Duerkop B.A., Clements C.V., Rollins D., Rodrigues J.L., Hooper L.V. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci U S A 2012, 109:17621-17626.
34. Basler M., Mekalanos J.J. Type 6 secretion dynamics within and between bacterial cells. Science 2012, 337:815.
35. Basler M., Ho B.T., Mekalanos J.J. Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell 2013, 152:884-894.
36. Fu Y., Waldor M.K., Mekalanos J.J. Tn-seq analysis of vibrio cholerae intestinal colonization reveals a role for t6ss-mediated antibacterial activity in the host. Cell Host Microbe 2013, 14:652-663.
37. Buffie C.G., Pamer E.G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013, 13:790-801.
38. Gallo R.L., Hooper L.V. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 2012, 12:503-516.
39. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
40. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., Schnabl B., DeMatteo R.P., Pamer E.G. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
41. Kinnebrew M.A., Buffie C.G., Diehl G.E., Zenewicz L.A., Leiner I., Hohl T.M., Flavell R.A., Littman D.R., Pamer E.G. Interleukin 23 production by intestinal cd103(+)cd11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012, 36:276-287.
42. Sonnenberg G.F., Fouser L.A., Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by il-22. Nat Immunol 2011, 12:383-390.
43. Mukherjee S., Zheng H., Derebe M.G., Callenberg K.M., Partch C.L., Rollins D., Propheter D.C., Rizo J., Grabe M., Jiang Q.X., Hooper L.V. Antibacterial membrane attack by a pore-forming intestinal c-type lectin. Nature 2014, 505:103-107.
44. Zelante T., Iannitti R.G., Cunha C., De Luca A., Giovannini G., Pieraccini G., Zecchi R., D'Angelo C., Massi-Benedetti C., Fallarino F., Carvalho A., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013, 39:372-385.
45. Sonnenberg G.F., Monticelli L.A., Elloso M.M., Fouser L.A., Artis D. Cd4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011, 34:122-134.
46. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.J., Thiam K., Cerf-Bensussan N., Mandelboim O., Eberl G., et al. Microbial flora drives interleukin 22 production in intestinal nkp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
47. Qiu J., Guo X., Chen Z.M., He L., Sonnenberg G.F., Artis D., Fu Y.X., Zhou L. Group 3 innate lymphoid cells inhibit t-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 2013, 39:386-399.
48. Zenewicz L.A., Yin X., Wang G., Elinav E., Hao L., Zhao L., Flavell R.A. Il-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol 2013, 190:5306-5312.
49. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., Tanoue T., et al. Induction of intestinal th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
50. Shaw M.H., Kamada N., Kim Y.G., Nunez G. Microbiota-induced il-1beta, but not il-6, is critical for the development of steady-state th17 cells in the intestine. J Exp Med 2012, 209:251-258.
51. Chen V.L., Surana N.K., Duan J., Kasper D.L. Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in salmonella infection. PLoS ONE 2013, 8:e65405.
52. Molloy M.J., Grainger J.R., Bouladoux N., Hand T.W., Koo L.Y., Naik S., Quinones M., Dzutsev A.K., Gao J.L., Trinchieri G., Murphy P.M., et al. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 2013, 14:318-328.
53. Grainger J.R., Wohlfert E.A., Fuss I.J., Bouladoux N., Askenase M.H., Legrand F., Koo L.Y., Brenchley J.M., Fraser I.D., Belkaid Y. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med 2013, 19:713-721.
54. Naik S., Bouladoux N., Wilhelm C., Molloy M.J., Salcedo R., Kastenmuller W., Deming C., Quinones M., Koo L., Conlan S., Spencer S., et al. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
55. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., Iwasaki A. Microbiota regulates immune defense against respiratory tract influenza a virus infection. Proc Natl Acad Sci U S A 2011, 108:5354-5359.
56. Abt M.C., Osborne L.C., Monticelli L.A., Doering T.A., Alenghat T., Sonnenberg G.F., Paley M.A., Antenus M., Williams K.L., Erikson J., Wherry E.J., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
57. Ganal S.C., Sanos S.L., Kallfass C., Oberle K., Johner C., Kirschning C., Lienenklaus S., Weiss S., Staeheli P., Aichele P., Diefenbach A. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
58. Alenghat T., Osborne L.C., Saenz S.A., Kobuley D., Ziegler C.G., Mullican S.E., Choi I., Grunberg S., Sinha R., Wynosky-Dolfi M., Snyder A., et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature 2013, 504:153-157.
59. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., Fukuda S., Saito T., Narushima S., Hase K., Kim S., et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 2013, 500:232-236.
60. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., Rudensky A.Y. Metabolites produced by commensal bacteria promote peripheral regulatory t-cell generation. Nature 2013, 504:451-455.
61. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., Takahashi M., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory t cells. Nature 2013, 504:446-450.
62. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 2013, 341:569-573.
63. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., Gaynor E.C., Finlay B.B. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe 2007, 2:204.
64. Haag L.M., Fischer A., Otto B., Plickert R., Kuhl A.A., Gobel U.B., Bereswill S., Heimesaat M.M. Intestinal microbiota shifts towards elevated commensal escherichia coli loads abrogate colonization resistance against campylobacter jejuni in mice. PLoS ONE 2012, 7:e35988.
65. Winter S.E., Winter M.G., Xavier M.N., Thiennimitr P., Poon V., Keestra A.M., Laughlin R.C., Gomez G., Wu J., Lawhon S.D., Popova I.E., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
66. Thiennimitr P., Winter S.E., Winter M.G., Xavier M.N., Tolstikov V., Huseby D.L., Sterzenbach T., Tsolis R.M., Roth J.R., Baumler A.J. Intestinal inflammation allows salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci U S A 2011, 108:17480-17485.
67. Gill N., Ferreira R.B., Antunes L.C., Willing B.P., Sekirov I., Al-Zahrani F., Hartmann M., Finlay B.B. Neutrophil elastase alters the murine gut microbiota resulting in enhanced salmonella colonization. PLoS ONE 2012, 7:e49646.
68. Pacheco A.R., Curtis M.M., Ritchie J.M., Munera D., Waldor M.K., Moreira C.G., Sperandio V. Fucose sensing regulates bacterial intestinal colonization. Nature 2012, 492:113-117.
69. Lamichhane-Khadka R., Kwiatkowski A., Maier R.J. The hyb hydrogenase permits hydrogen-dependent respiratory growth of salmonella enterica serovar typhimurium. MBio 2010, 1.
70. Maier L., Vyas R., Cordova C.D., Lindsay H., Schmidt T.S., Brugiroux S., Periaswamy B., Bauer R., Sturm A., Schreiber F., von Mering C., et al. Microbiota-derived hydrogen fuels salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe 2013, 14:641-651.
71. Maier R.J., Olczak A., Maier S., Soni S., Gunn J. Respiratory hydrogen use by salmonella enterica serovar typhimurium is essential for virulence. Infect Immun 2004, 72:6294-6299.
72. Kane M., Case L.K., Kopaskie K., Kozlova A., MacDearmid C., Chervonsky A.V., Golovkina T.V. Successful transmission of a retrovirus depends on the commensal microbiota. Science 2011, 334:245-249.
73. Kuss S.K., Best G.T., Etheredge C.A., Pruijssers A.J., Frierson J.M., Hooper L.V., Dermody T.S., Pfeiffer J.K. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011, 334:249-252.
74. Robinson C.M., Jesudhasan P.R., Pfeiffer J.K. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 2014, 15:36-46.
75. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.